EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline

GLASGOW, Scotland, Sept. 7, 2021 -- (Healthcare Sales & Marketing Network) -- EnteroBiotix, a biopharmaceutical company developing novel high-diversity microbial therapeutics that enhance the gut microbiome and target multiple indications, today announced... Biopharmaceuticals, Venture Capital EnteroBiotix, gut microbiome
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news